NL-based DSM to merge with Firmenich in shares and cash deal

Date: 2022-06-01   Author: Pankaj Singh  Category: #news

NL-based DSM to merge with Firmenich in shares and cash deal

Dutch multinational corporation DSM N.V. has reportedly planned to merge with Firmenich, the world’s largest perfumery and taste company in a mega cash and share deal.

The merger is expected to augment annual sales by USD 537 million, particularly by consolidating Firmenich’s Taste & Beyond and DSM’s Food & Beverage businesses.

Initially, DSM stakeholders will own around 65.5% of the merged entity, and the Firmenich stakeholders will own around 34.5% of the merged company, receiving USD 3.8 billion in cash.

The merger is anticipated to be executed in the first half of next year, and the newly merged company will be listed on Euronext Amsterdam and domiciled in Switzerland.

DSM-Firmenich will possess integrated capabilities across taste, fragrance, nutrition, and texture, boosted by high-quality science.

Both parties stated that this merger will be between two companies with a thriving track record and a common objective to have a positive impact on the people as well as the planet.

Thomas Leysen, Chairman of the DSM Supervisory Board mentioned that the DSM-Firmenich merger will introduce advanced science, innovation, and leading creativity.

The merger will bring together close to 28,000 people. The global Perfumery and Ingredients business of Firmenich will further expand into Beauty with the inclusion of the Personal Care & Aroma business of DSM.

The merged entity also intends to form a new global-scale partner to cater to the F&B industry, consolidating Firmenich’s Taste & Beyond and DSM’s Food & Beverage businesses.

The new consolidated businesses will be joined by DSM’s Nutrition & Care, Health, and Animal Nutrition & Health businesses.

The merger will introduce an alluring yearly run rate synergy of USD 375 million adjusted with EBITDA with an expected mid-term sustainable organic sales growth of 5% to 7% driven by innovation. Both companies expect a 22-23% mid-term adjusted EBITDA margin backed by synergies.

Source credit:

About Author

Pankaj Singh linkdin-boxtwitter

Pankaj Singh

Pankaj Singh Develops content for Algosonline, Market Size Forecasters, and a couple of other platforms. A Post Graduate in Management by qualification, he worked as an underwriter in the UK insurance domain before deciding to switch his field of profession. With exp...

Read More

Post Recommendents

Antenatal Screening Market Share, By Product Analysis, Application, End-Use, Regional Outlook, Competitive Strategies & Forecast up to 2028

Author: Ashwin Naphade

Global Antenatal Screening Market, 2022-2028 Research Report provides crucial statistics on the market status of the Global Antenatal Screening manufacturers and is a respected source of guidance and direction for companies and individuals interes...

Pediatric Vitrectomy Market Size | Global Industry Analysis, Segments, Top Key Players, Drivers and Trends to 2028

Author: Ashwin Naphade

Global Pediatric Vitrectomy market report provides major statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

The Pediatric Vitrectomy market repor...

Legionnaire Disease Testing Market Comprehensive Analysis, Share, Growth Forecast from 2022 to 2028c

Author: Ashwin Naphade

This report studies the Global Legionnaire Disease Testing market status and outlook of global and major regions, from angles of players, regions, product types and end industries; this report analyzes the top players in global and major regions, ...